Life science investments
The company buys, holds, and helps finance stakes in pharmaceutical and other life science businesses, often through direct ownership or partnership deals.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Pharma Equity Group A/S is a Danish investment and development company focused on pharmaceuticals and life sciences. It does not sell drugs itself; instead, it builds and backs early-stage healthcare and biotech businesses, often around drug development, licensing, and commercialization opportunities. Its role is closer to a specialized owner and builder of pharma assets than a traditional operating drugmaker.
The company makes money mainly by owning stakes in portfolio companies and by helping create value in those businesses over time. That can include supporting clinical development, finding partners, structuring deals, and helping move assets toward licensing or sale. In practice, its customers are the scientific teams, partner companies, and investors who participate in these ventures, while the end markets are the patients, doctors, and drug companies that use or acquire the resulting therapies.
What makes its business model different is that it sits between pure finance and pure drug development. Pharma Equity Group takes on the early risk of building healthcare assets, but it also tries to create exits through partnerships or transactions rather than relying only on long-term product sales. That makes it a specialized vehicle for turning pharmaceutical ideas into investable company assets.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more